Xenon Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Xenon Pharmaceuticals Inc. (Nasdaq:XENE) has announced participation in one-on-one investor meetings and a fireside chat at the 21st Annual Needham (Virtual) Healthcare Conference on April 11, 2022. The fireside chat will occur from 10:15-10:55 am Eastern Time, featuring Ian Mortimer, President and CEO, and Sherry Aulin, CFO. Recordings of the presentation will be available post-event on their website. The company is dedicated to developing innovative therapies for neurological disorders, particularly focusing on epilepsy.

BURNABY, British Columbia, April 04, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that management will participate in one-on-one investor meetings and a fireside chat at the 21^st Annual Needham (Virtual) Healthcare Conference.

Fireside Chat Details:

Date:	Monday, April 11, 2022
Time:	10:15-10:55 am Eastern Time
Presenters:	Ian Mortimer, President and CEO; Sherry Aulin, Chief Financial Officer

Details on company presentations and webcasts can be found on the “Investors” section of Xenon’s website at investor.xenon-pharma.com. When available, webcasts will be posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com

FAQ

What date is the Xenon Pharmaceuticals fireside chat?

The fireside chat for Xenon Pharmaceuticals is scheduled for April 11, 2022.

What time will the Xenon Pharmaceuticals fireside chat take place?

The fireside chat will take place from 10:15 to 10:55 am Eastern Time.

Who are the presenters for the Xenon Pharmaceuticals fireside chat?

The presenters are Ian Mortimer, President and CEO, and Sherry Aulin, Chief Financial Officer.

Where can I find more information about the Xenon Pharmaceuticals conference?

More information can be found on the 'Investors' section of Xenon Pharmaceuticals' website.

What is the focus of Xenon Pharmaceuticals?

Xenon Pharmaceuticals focuses on developing innovative therapeutics for neurological disorders, with a particular emphasis on epilepsy.